Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Promoter methylation of RASSF1A, RARβ and DAPK predict poor prognosis of patients with malignant mesothelioma

8 Aug 2006

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Neonatal Respiratory Health Research
Share to Occupational and environmental lung diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16893590
DOI: 10.1016/j.lungcan.2006.06.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Promoter methylation of RASSF1A, RARβ and DAPK predict poor prognosis of patients with malignant mesotheliomaPMID 16893590Read ↗

Prospective Analysis of Mesotheliomas in Subjects With BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of DiseaseSemantic proximity Read ↗

Gene methylation in pleural mesothelioma: Correlations with clinico-pathological features and patient's follow-upSemantic proximity Read ↗

DNA methylation profile of 28 potential marker loci in malignant mesotheliomaSemantic proximity Read ↗

Molecular Changes in Mesothelioma With an Impact on Prognosis and TreatmentSemantic proximity Read ↗

Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lungSemantic proximity Read ↗

Inactivation of p16INK4a expression in malignant mesothelioma by methylationSemantic proximity Read ↗

Prognostic Value of EMT Gene Signature in Malignant MesotheliomaSemantic proximity Read ↗

Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesotheliomaSemantic proximity Read ↗

Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesotheliomaSemantic proximity Read ↗

Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesotheliomaSemantic proximity Read ↗

DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic MimicsSemantic proximity Read ↗

Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.